Tag: English

New York, NY, October 23, 2025 – Following a challenge from competitor Tailor Brands Ltd., BBB National Programs’ National Advertising Division found certain ZenBusiness Inc. filing guarantee, “one-day processing,” and “businesses started” claims for its LLC formation services supported, but recommended ZenBusiness modify a challenged comparative claim.

Tailor Brands and ZenBusiness are competitors in the marketplace for business formation services and operate digital platforms designed to support businesses with LLC formation, registered agent services, and tax and financial services.

Accuracy of Filing Claims

At issue for the National Advertising Division (NAD) was the express claim that “ZenBusiness offers a performance guarantee of 100% accuracy in its filings” as well as the implied claim that ZenBusiness’s filings are more accurate than those of Tailor Brands.

NAD determined that ZenBusiness substantiated the claim that it offers a 100% accuracy guarantee. However, in the context of a comparison to Tailor Brands, NAD determined that one message reasonably conveyed is that, by contrast, Tailor Brands does not strive to provide accuracy or correct internal filing errors.

Accordingly, NAD recommended that ZenBusiness modify its advertising to avoid conveying the message that Tailor Brands does not work to provide accuracy in its filings.

One-Day Processing Claim

At issue for NAD was ZenBusiness’s claim that it will process LLC formations in one day, and whether this claim adequately disclosed that it refers only to ZenBusiness’s internal processing time, not any additional processing time by the Secretary of State.

During the proceeding, ZenBusiness stated it would modify its advertising to make clearer that one-day processing is not included with its “free” starter package.

NAD determined that the advertising is reasonably understood as referring only to ZenBusiness’s processing time, and that the disclosures are adequate. Accordingly, NAD concluded that the modified one-day processing claim is supported.

Number of Businesses Claims

At issue for NAD was the claim that ZenBusiness “has launched more than 800k successful businesses.”  During the proceeding, ZenBusiness stated it would voluntarily modify the claim to “800k+ businesses started,” omitting the description of the businesses as “successful.”

NAD determined that the modified claim regarding the number of businesses “started” or “formed” with assistance from ZenBusiness was supported.

During the proceeding, ZenBusiness voluntarily agreed to permanently discontinue a rating claim, modify certain claims to accurately reflect its pricing, policies, and ratings, and modify a celebrity endorsement to clearly and conspicuously disclose a material connection. Therefore, NAD did not review the claims on their merits and will treat the discontinued and modified claims, for compliance purposes, as though NAD recommended they be discontinued.

In its advertiser statement, ZenBusiness stated that it “will comply with NAD’s recommendation.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.

Contact:
Jennie Rosenberg
Media Relations
BBB National Programs
press@bbbnp.org

GREENVILLE, S.C., October 16, 2025 – Michelin, a global leader in tire innovation, is proud to announce the full deployment of TreadEye, a proprietary technology developed to enhance the retread process and deliver measurable value to fleets. After a period of phased implementation, TreadEye is now available across the Michelin Retread Technologies franchise network in the United States.

TreadEye is an industry-leading tread depth assessment tool that helps fleets maximize their tire investment—because every 32nd of an inch counts. The system accurately and consistently collects 1,200 measurement points, providing precise insights into tread wear and casing condition.

“TreadEye is a game-changer for our retread operations and for the fleets we serve,” said Nate Kirian, Vice President of Sales and Distribution, Commercial Business Lines for Michelin North America, Inc. “It’s a powerful example of how Michelin continues to innovate in ways that directly benefit our customers.”

Key benefits of TreadEye include identification of pull points by fleet location; maximization of rubber on the road by avoiding early pulls; helps in prevention of casing damage, helps reduce DOT violations, and downtime from late pulls; and improved efficiency in the tire removal process, directly impacting a fleet’s bottom line.

Learn more about Michelin Retread Technologies: business.michelinman.com/retreads.

About Michelin North America, Inc.

Michelin is a world-leading manufacturer of life-changing composites and experiences. Pioneering engineered materials for more than 130 years, Michelin is uniquely positioned to make decisive contributions to human progress and to a more sustainable world. Drawing on its deep knowledge in polymer composites, Michelin is constantly innovating to manufacture high-quality tires and components for critical applications in demanding fields as varied as mobility, construction, aeronautics, low-carbon energies and healthcare. The care placed in its products and deep customer knowledge inspire Michelin to offer the finest experiences. This spans from providing data- and AI-based connected solutions for professional fleets to recommending outstanding restaurants and hotels curated by the MICHELIN Guide.

Headquartered in Greenville, S.C., Michelin North America, Inc. has approximately 23,500 employees and operates 36 production facilities in the United States (michelinman.com) and Canada (michelin.ca).

For more information, contact:

Michelin North America
Public.relations@michelin.com
www.michelinmedia.com

New York, NY, October 16, 2025 – In a Fast-Track SWIFT challenge brought by AT&T Services, Inc., BBB National Programs’ National Advertising Division reviewed claims by Verizon Communications Inc. that it offers the Google Pixel 10 Pro for free on any plan.

Fast-Track SWIFT is an expedited process for single-issue advertising cases reviewed by the National Advertising Division (NAD).

AT&T alleged that Verizon’s Using A.I.: Google Pixel 10 Pro commercial included the implied claim that Verizon offers a free Google Pixel 10 Pro with any Verizon plan and that the commercial’s disclosures did not inform consumers that the offer was only for Verizon Unlimited Ultimate customers.  

During the inquiry, Verizon informed NAD that the commercial was permanently discontinued. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

New York, NY, October 15, 2025 – BBB National Programs’ National Advertising Division reviewed a challenge brought by Advantice Health regarding express claims made by XF Agencija, d/b/a Lunavia. The challenge pertained to claims appearing on Lunavia’s website, social media, and third-party retailer pages regarding the benefits and efficacy of its antifungal nail pen.

During the inquiry, Lunavia informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

In 2024, claimants filed a record number of federal lawsuits challenging coverage under business liability policies – and they are on pace to file even more this year.

San Jose, CA — October 14, 2025 — Lex Machina®, the LexisNexis® Legal Analytics® platform, today announced the release of its 2025 Insurance Litigation Report, providing a comprehensive analysis of insurance litigation in US federal courts since 2015. The report gives legal and insurance professionals impactful data and exclusive insights into the modern era of coverage disputes.

Key findings from the report include:

• Rise of Business Liability Policy Disputes: Lawsuits concerning businesses’ liability coverage have increased significantly in federal courts each year since 2022, following a long period of stability. In 2024, over 3,000 business liability coverage lawsuits were initiated in federal district courts – more than in any year since 2010.
• Staying Power of Business Interruption Claims: Lawsuits seeking coverage under business interruption policies persist on the federal litigation scene even as such claims based on Covid-19 closures have passed their limitations periods. In 2024, more than 650 business-interruption coverage lawsuits were filed, a figure over 50% higher than any year from 2009 to 2019.

• Homeowners Policy Coverage Disputes are Climbing, Independent of Hurricanes: Excluding cases related to hurricanes, homeowner policy insurance cases have become significantly more frequent each year since 2018. In 2024, over 3,500 such lawsuits were launched in federal district courts – more than in any other year since at least 2009. Data from Lex Machina for January through September 2025 indicates another increase this year compared to last.

“The Insurance Litigation Report offers a detailed and comprehensive analysis of the trends influencing insurance litigation in federal courts,” said Sue Zago, Law Library Director and Professor of Law at the University of New Hampshire Franklin Pierce School of Law. “Utilizing the power of Lex Machina, this report provides an extensive dataset that enables lawyers to monitor trends among leading law firms and judges in areas such as general insurance, business liability, business interruption, hurricane-related claims, homeowners policies, and life insurance policies. A valuable tool!”

“Insurance litigation saw several pandemic-related spikes in 2021 and 2022 as certain types of coverage were in the spotlight. As we move further away from those years, different patterns are emerging with respect to the types of coverage that are the subject of litigation in the federal courts,” said Ron Porter, Lex Machina Practice Lead for Insurance Litigation Analytics. “The data also show that the increasing number and severity of hurricanes and other weather events drives case filings in affected jurisdictions.”

To learn more practical implications of the data trends noted in the 2025 Insurance Litigation Report, register now for our complimentary webinar on Wednesday, October 15, 2025, at 4:00 pm ET: The 2025 Lex Machina Insurance Litigation Report: Critical Insights Revealed. All attendees will receive a copy of the report. Not able to attend? Request a copy of the report at LexisNexis.com/LexMachina.  

The Lex Machina Legal Analytics platform equips litigation professionals to win more cases and attract more business. From precise timing metrics that inform legal budgeting to trend data on top law firms and leading judges, Lex Machina uniquely supplements traditional legal research and experience with customized, data-backed insights. These insights help lawyers identify prospective clients, navigate motion and trial strategies, and negotiate smarter settlements, ultimately giving firms a competitive edge in litigation.

About LexisNexis Legal & Professional 

LexisNexis® Legal & Professional provides legal, regulatory, and business information and analytics that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis® and Nexis® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,800 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. 

About Lex Machina 

Lex Machina fundamentally changes how companies and law firms compete in the business and practice of law. The company provides strategic insights on judges, lawyers, law firms, parties, and other critical information across 22 federal practice areas and a rapidly growing number of state courts. Lex Machina allows law firms and companies to anticipate the behaviors and outcomes that different legal strategies will produce, enabling them to win cases and close business. 

Lex Machina was named one of Forbes’ Best Workplaces in the Bay Area in 2024, Winner of the “Media Excellence Award” for Analytics/Big Data 2024, “Great Places to Work” (2023-2024), one of “Legal Tech’s Most Promising Solution Providers” (CIO Review Awards 2022), “Greater Bay Area Top Workplaces 2022” (The San Francisco Chronicle Top Workplaces in the Bay Area 2022), “Legal Tech Company of the Year 2021″ (CIO Review, 2021), “2021 Legal Technology Trailblazer” (National Law Journal Trailblazer Awards, 2021), and Winner of the “Media Excellence” Award for Analytics/Big Data (13th Annual Media Excellence Award, 2021). Based in Silicon Valley, Lex Machina is part of LexisNexis, a leading global provider of legal, regulatory, and business information and analytics. For more information, please visit www.lexmachina.com.

Media Contact

Venture PR lexmachina@venturepr.co 

New York, NY – October 13, 2025 – In a challenge brought by Niagen Bioscience Inc., BBB National Programs’ National Advertising Division found certain Reus Research LLC claims for its Cata-Kor NAD+ Core and Cata-Kor NAD+ Advanced products supported.

However, the National Advertising Division (NAD) recommended other Reus claims be modified or discontinued after determining that some statements regarding product content and health benefits lacked sufficient substantiation, that certain influencer posts require clear and conspicuous disclosures, and that product ratings and reviews for substantially different products should not be combined.

Niagen and Reus compete in the dietary supplement industry. At issue for NAD were challenged express and implied claims for Cata-Kor products across product labels, website and Amazon product pages, and social media. The Cata-Kor Products contain nicotinamide adenine dinucleotide (NAD+).

Ingredient Content Claims

At issue were claims that Cata-Kor NAD+ Core contains 250 mg LipoNAD+ and Cata-Kor NAD+ Advanced contains 500 mg LipoNAD+. Among other places, the claims appear on the product packages, referring to “NAD+ Core … 250 mg” or “NAD+ Advanced… 500 mg.” According to Reus, the declared weights include the liposomal layer in which the NAD+ is encased.

Absent reliable consumer perception evidence, NAD determined that consumers would expect that the stated weight was the total amount of NAD+ in the product and therefore recommended that Reus discontinue these claims when made outside of the supplement facts panel on the product label or modify the advertising to avoid conveying the message that each dose or capsule of Cata-Kor NAD+ Core contains 250 mg of NAD+ and that each dose or capsule of Cata-Kor NAD+ Advanced product contains 500 mg of NAD+.

Ingredient Testing Claims

At issue were express testing claims as well as the implied claim that all lots of NAD+ products are third-party tested, verified, and certified for ingredient content and purity.

Although there is no methodology for testing LipoNAD+, Reus tested for NAD+ and followed an FDA-approved method for calculating and reporting a substance for which there is not a validated testing methodology. NAD found that Reus’s approach supported its basic third-party ingredient testing claims and for the claim that all lots of NAD+ Products were tested by a third-party lab.

Regarding its purity testing claims, NAD found that these claims convey the message that Reus’s products contain pure NAD+, which is not the case based on Reus’s own testing. NAD recommended that the purity claims be discontinued or modified to avoid conveying that Reus’s products contain pure NAD+.

Health Claims

At issue was whether the NAD+ in Cata-Kor’s Products influences NAD+ levels in the body. It is well settled that health-related product performance claims must be supported by competent and reliable scientific evidence on the actual product as it is marketed to consumers. Reus did not submit and there did not appear to be any human clinical studies on the oral ingestion of NAD+, whether liposomal or otherwise. In addition, Reus did not conduct any testing on the Cata-Kor Products themselves to support any of the challenged health claims or to show that the products influence NAD+ levels in the body.

NAD found that there was no evidence in the record to support Reus’s health or establishment claims related to the NAD+ in its products and therefore recommended Reus discontinue the challenged health claims.

Influencer Disclosures

At issue was if Reus incentivized influencers to promote Cata-Kor Products on TikTok without adequately disclosing their connections.

NAD found that the challenged TikTok posts require a clear and conspicuous material connection disclosure and found no support for the argument that because an influencer linked to a TikTok shop, consumers would know the influencer had a material connection to the seller. NAD also found that including a TikTok store link does not itself disclose a material connection. Furthermore, NAD found that TikTok’s built in disclosure tool, “Creator earns commission,” which appears at the bottom left portion of videos and is relatively small, could be easily missed by consumers.

NAD recommended that Reus require its influencers to clearly and conspicuously display material connection disclosures in the audio and visual portions of their videos.

Review Repurposing

At issue was whether Reus had engaged in review repurposing by having reviews for its prior product containing nicotinamide riboside (NR), a different active ingredient, included in the reviews for Cata-Kor NAD+ Advanced.

Because the NAD+ Products and the NR product are substantially different products, NAD advised that their product ratings and reviews should not be combined. NAD recommended that Reus take appropriate actions to have reviews for the NR product removed from the product page selling Cata-Kor NAD+ Advanced.

During the proceeding, Reus voluntarily agreed to permanently discontinue all comparative superiority claims, doctor recommendation claims, Made in USA claims, and certain content, testing, and health claims as well as the related challenged implied claims. NAD will treat these claims for compliance purposes, as though NAD recommended they be discontinued.

In its advertiser’s statement, Reus stated they “will comply with NAD’s recommendations.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Pursuant to NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.

64% of tax practitioners are now using generative AI in their work, but unclear policies and slow-moving cultures risk stalling progress. Meanwhile, client demand is pushing tax practices towards value-led and subscription-based pricing.

LONDON, 13 October 2025 – Today, Tolley®, part of LexisNexis® Legal & Professional, released a new report – The AI pricing shift in tax. The findings show adoption of AI tools is accelerating at pace, with 64% of tax professionals now using AI in their day-to-day work, compared to 40% in February 2025. The proportion of practitioners with no plans to adopt AI remains low at just 8%.

AI is rapidly becoming embedded in tax workflows. Four-fifths (80%) of users say its main benefit is delivering work faster, while 70% cite improved client service and 55% highlight competitive advantage. Yet only 15% of tax professionals say AI is fully embedded in their strategy and operations, with most describing adoption as slow, experimental, or underfunded.

The report also reveals how AI is transforming client expectations around pricing. While billable hours remain dominant, many firms are already experimenting with fixed fees (41%), flat fees (38%), or phased pricing (20%). Interest is growing in AI-enabled billing models, with 26% of respondents considering subscription-based services and 20% exploring bundled offerings that combine AI outputs with expert review.

Commenting on the findings, Jonathan Scriven, Director of Tax Markets at LexisNexis, said:

“AI is fundamentally changing the economics of tax. Faster workflows and smarter insights are challenging the billable hour and creating pressure for value-led pricing. Organisations that adapt quickly will not only meet client expectations but also attract top talent and strengthen trust in their services.”

The report also highlights a potential talent risk for teams that fail to invest. One in five tax practitioners (20% private practice, 23% in-house) said they would consider leaving their organisation if it does not adequately adopt AI.

About Tolley and LexisNexis Legal & Professional

Tolley is part of LexisNexis^® Legal & Professional. It provides answers to tax specialists throughout their tax career. Covering all tax areas, Tolley’s core products offer intellectual tax guidance, the latest research and career development paths for every tax professional. LexisNexis Legal and Professional provides legal, regulatory, and business information and analytics that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis^® and Nexis^® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,300 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. 

Media Contact

Matthew Leopold – Head of Brand, Content and PR Marketing, LexisNexis UK

Email: Matthew.Leopold@lexisnexis.co.uk

 

Notes for editors

• This press release is embargoed until 00:01 on 13 October, 2025
• You can view the report here:  https://www.lexisnexis.co.uk/tolley/tax/insights/tax-ai-report-h2-2025-tolley/index.html

GREENVILLE, S.C., October 09, 2025 – Michelin and the International Motor Sports Association (IMSA) today announced a multi-year extension of their longstanding partnership, reinforcing Michelin’s role as the Official Tire of IMSA and exclusive tire supplier for the IMSA WeatherTech SportsCar Championship, IMSA Michelin Pilot Challenge and IMSA VP Racing Sportscar Challenge.

The renewed agreement underscores Michelin’s commitment to endurance racing as a testing environment for advanced materials science, including high-tech polymers and flexible composite materials, that drives innovation and sustainability across both motorsports and consumer tires.

“Michelin has been innovating for more than 130 years, and competition has always been at the heart of that journey,” said Alexis Garcin, executive vice president of Michelin. “From the first removable bicycle tire to the Pilot Sport Endurance range, many of our breakthroughs have consistently come from the racetrack. IMSA gives us a competitive ecosystem to validate new technologies under real pressure, and that’s exactly where Michelin thrives.”

This long-term partnership with IMSA reinforces Michelin’s motorsports strategy by anchoring innovation in competition and accelerating the transfer of race-proven technologies to road-going products. Endurance racing, in particular, provides the ultimate proving ground, where durability, longevity and performance are tested like nowhere else.

Michelin is expanding its race-proven technologies across a wider range of products. By leveraging advanced tread compounds, cutting-edge simulation tools, and data integrated tools, teams are unlocking peak performance—on the track and beyond

“Michelin has been a cornerstone of IMSA’s success,” said John Doonan, IMSA president. “Their technical expertise and commitment to innovation have elevated the level of competition across our series. We’re proud to continue this journey together.”

As IMSA continues to push the boundaries of innovation in racing, including hybrid powertrains, electrification and global convergence in sports car racing, Michelin will remain a key technical partner, helping shape the future of mobility through competition.

About Michelin North America, Inc.

Michelin is a world-leading manufacturer of life-changing composites and experiences. Pioneering engineered materials for more than 130 years, Michelin is uniquely positioned to make decisive contributions to human progress and to a more sustainable world.

Drawing on its deep knowledge in polymer composites, Michelin is constantly innovating to manufacture high-quality tires and components for critical applications in demanding fields as varied as mobility, construction, aeronautics, low-carbon energies and healthcare.

The care placed in its products and deep customer knowledge inspire Michelin to offer the finest experiences. This spans from providing data- and AI-based connected solutions for professional fleets to recommending outstanding restaurants and hotels curated by the MICHELIN Guide.

Headquartered in Greenville, S.C., Michelin North America, Inc. has approximately 23,500 employees and operates 36 production facilities in the United States (michelinman.com) and Canada (michelin.ca).

New York, NY, October 8, 2025 – BBB National Programs’ National Advertising Division reviewed a challenge brought by Novo Nordisk, Inc. regarding express and implied advertising claims made by Medicine Center Pharmacy (MCP) concerning the benefits, efficacy, and safety of its compounded sublingual semaglutide products that appeared on MCP’s website and social media pages.

During the inquiry, MCP informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended, they be discontinued.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.  

New York, NY – October 7, 2025 – In a challenge brought by competitor Sanofi, BBB National Programs’ National Advertising Division found certain Galderma Laboratories, L.P. itch relief claims supported, but recommended that Galderma modify or discontinue claims that its drug, Nemluvio, provides itch relief “as soon as 48 hours” for patients with moderate-to-severe atopic dermatitis (eczema) or prurigo nodularis (PN).

Sanofi and Galderma are competitors in the pharmaceutical space. Galderma’s Nemluvio is a monoclonal antibody approved by the FDA to treat adults with PN, and to treat moderate-to-severe eczema in those 12 years of age and older when used in combination with topical therapies.

At issue for the National Advertising Division (NAD) was whether express and implied claims on webpages and in social media communicated “instantaneous itch relief,” the appropriateness of Galderma’s reliance upon post hoc analyses to support its “as soon as 48 hours” itch relief claims, and whether appreciable numbers of patients obtain itch relief as quickly as claimed.

Instantaneous Itch Relief Claims

On webpages directed to health care professionals (HCPs), under language about Nemluvio being approved for adults and adolescents with eczema or being approved for adults with PN, was the headline “Itch relief like that” together with an image of a woman snapping her fingers.

NAD determined that the qualifying statement “A novel, IL-31RA-targeted biologic that

delivers itch relief as soon as 48 hours” under the image was clear, conspicuous, and reasonably close to the headline, adequately limiting the fast-itch-relief message. NAD also found that the webpages did not communicate an instantaneous itch relief claim.

In addition, NAD evaluated a survey submitted by Galderma of 300 dermatologists, half seeing the test ad and half a control ad with the headline changed to “Itch relief as soon as 48 hours.” No more than 3.3% of those seeing the test ad and 1.3% of those seeing the control ad interpreted the message as instantaneous. NAD determined the survey was reliable and showed that dermatologists did not take away an implied claim of instantaneous itch relief from the eczema-focused HCP ad.

“As Soon as 48 Hours” Claims

NAD reviewed the express “as soon as 48 hours” claims on the HCP webpages and one directed to consumers and found that the ads conveyed the message that Nemluvio provides itch relief within 48 hours from treatment to appreciable numbers of eczema and PN patients.

NAD also found that the disclosures about study results, which refer to a “Phase 3 clinical study,” conveyed the message that the 48-hour itch relief claims were clinically proven and that Nemluvio advertising communicated that the within-48-hours-from-treatment claims were clinically proven.

After reviewing the evidence, NAD determined that Galderma’s post hoc analyses were reliable and that Galderma did not need to explain the purported limitations of those analyses in the challenged advertising. NAD determined, however, that unqualified “as soon as 48 hours” claims were not supported, as only 6% of eczema patients and 13% of PN patients achieved significant itch relief in 48 hours after netting control results. An “as soon as” claim is functionally equivalent to an “up to” claim and requires that an appreciable number of consumers obtain the stated benefit.

NAD found that Galderma’s disclosures regarding the incidence of 48-hour relief were inconspicuous and would be difficult for ordinary consumers to decipher. Therefore, NAD recommended that Galderma discontinue or modify “as soon as 48 hours” claims by disclosing clearly, conspicuously, and in close proximity either the percentages of patients obtaining 48-hour itch relief in the treatment and placebo groups or the percentage after netting the placebo. If such claims are made in the audio portion of an ad, the disclosure would need to be made in the audio portion to be clear and conspicuous.

During the proceeding, Galderma voluntarily agreed to permanently discontinue using the finger-snap imagery with the “Itch Relief Like That” statement in advertising directed to consumers. NAD will treat these claims, for compliance purposes, as though NAD recommended they be discontinued.

In its advertiser’s statement, Galderma stated it “will comply with NAD’s recommendations regarding Nemluvio advertising.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Pursuant to NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.